Different Cutoff Values for Increased Nuchal Translucency in First-Trimester Screening to Predict Fetal Chromosomal Abnormalities

References

• Giorlandino C, Cignini P, Padula F, et al. Effects of exogenous progesterone on fetal nuchal translucency: an observational prospective study. Am J Obstet Gynecol. 2015;212:335.e1-e7. doi:10.1016/j.ajog.2014.10.003
   PubMed Web of Science ®Google Scholar
• Baer RJ, Norton ME, Shaw GM, et al. Risk of selected structural abnormalities in infants after increased nuchal translucency measurement. Am J Obstet Gynecol. 2014;211:675 e1–19. doi:10.1016/j.ajog.2014.06.025
   PubMed Web of Science ®Google Scholar
• Kagan KO, Avgidou K, Molina FS, et al. Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstet Gynecol. 2006;107:6–10. doi:10.1097/01.AOG.0000191301.63871.c6
   PubMed Web of Science ®Google Scholar
• Syngelaki A, Guerra L, Ceccacci I, et al. Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first‐trimester screening for chromosomal abnormalities. Ultrasound Obstet Gynecol. 2017;50:45–48. doi:10.1002/uog.17286
   PubMed Web of Science ®Google Scholar
• Wulff CB, Gerds TA, Rode L, et al. The risk of fetal loss associated with invasive testing following combined first trimester risk screening for Down syndrome - a national cohort of 147 987 singleton pregnancies. Ultrasound Obstetr Gynecol. 2016;47:38–44. doi:10.1002/uog.15820
   PubMed Web of Science ®Google Scholar
• Hellmuth SG, Pedersen LH, Miltoft CB, et al. Increased nuchal translucency thickness and risk of neurodevelopmental disorders. Ultrasound Obstetr Gynecol. 2017;49:592–598. doi:10.1002/uog.15961
   PubMed Web of Science ®Google Scholar
• Miranda J, Paz YMF, Borobio V, et al. Can cell-free DNA testing be used in pregnancies with increased nuchal translucency? Ultrasound Obstet Gynecol. 2019;34(4):624–628.
   Google Scholar
• Hadlock FP, Shah YP, Kanon DJ, et al. Fetal crown-rump length: reevaluation of relation to menstrual age (5–18 weeks) with high-resolution real-time US. Radiology. 1992;182:501–505. doi:10.1148/radiology.182.2.1732970
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ. 1992;304:867. doi:10.1136/bmj.304.6831.867
   PubMed Web of Science ®Google Scholar
• Khalil A, Mahmoodian N, Kulkarni A, et al. Estimation of detection rates of aneuploidy in high-risk pregnancy using an approach based on nuchal translucency and non-invasive prenatal testing: a cohort study. Fetal Diagn Ther. 2015;38:254–261. doi:10.1159/000381182
   PubMed Web of Science ®Google Scholar
• Yaron Z, Roni Z, Zvi K. The added value of detailed early anomaly scan in fetuses with increased nuchal translucency. Prenat Diagn. 2017;37:235–243. doi:10.1002/pd.4997
   PubMed Web of Science ®Google Scholar
• Bardi F, Bosschieter P, Verheij J, et al. Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening? Prenat Diagn. 2019;40:197–205. doi:10.1002/pd.5590
   PubMed Web of Science ®Google Scholar
• Sivanathan J, Thilaganathan B. Book: genetics for obstetricians and gynaecologists: chapter:Genetic markers on ultrasound scan. Best Pract Res Clin Obstet Gynaecol. 2017;42:64–85.
   PubMed Web of Science ®Google Scholar
• Hsiao CH, Cheng PJ, Shaw S, et al. Extended first-trimester screening using multiple sonographic markers and maternal serum biochemistry: a five-year prospective study. Fetal Diagn Ther. 2014;35:296–301. doi:10.1159/000357564
   PubMed Web of Science ®Google Scholar
• Su L, Huang H, An G, et al. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype. Mol Genet Genom Med. 2019;7:e811. doi:10.1002/mgg3.811
   PubMed Web of Science ®Google Scholar
• Sinajon P, Chitayat D, Roifman M, et al. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol. 2020;55:383–390. doi:10.1002/uog.20352
   PubMed Web of Science ®Google Scholar
• Yräs O, Eronen M, Tikkanen M, et al. Long-term neurodevelopmental outcome of children from euploid pregnancies with increased nuchal translucency in the first trimester screening. Prenat Diagn. 2015;35:362–369. doi:10.1002/pd.4548
   PubMed Web of Science ®Google Scholar
• De La Paz-gallardo MJ, García FSM, De Haro-muñoz T, et al. Quantitative-fluorescent-PCR versus full karyotyping in prenatal diagnosis of common chromosome aneuploidies in southern Spain. Clin Chem Lab Med. 2015;53:1333–1338. doi:10.1515/cclm-2014-0781
   PubMed Web of Science ®Google Scholar
• Meyberg-Solomayer G, Hamza A, Takacs Z, et al. The significance of anterolateral neck cysts in early diagnosis of fetal malformations. Prenat Diagn. 2016;36:332–337. doi:10.1002/pd.4785
   PubMed Web of Science ®Google Scholar
• Kagan KO, Sonek J, Sroka A, et al. False-positive rates in screening for trisomies 18 and 13: a comparison between first-trimester combined screening and a cfDNA-based approach. Arch Gynecol Obstet. 2019;299:431–437. doi:10.1007/s00404-018-4983-2
   PubMed Web of Science ®Google Scholar
• Reiff ES, Little SE, Dobson L, et al. What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy? Prenat Diagn. 2016;36:260–265. doi:10.1002/pd.4774
   PubMed Web of Science ®Google Scholar
• Mack LM, Lee W, Mastrobattista JM, et al. Are first trimester nuchal septations independent risk factors for chromosomal anomalies? J Ultrasound Med. 2017;36:155–161. doi:10.7863/ultra.16.01066
   PubMed Web of Science ®Google Scholar
• Mak A, Lee H, Poon CF, et al. Factors associated with common and atypical chromosome abnormalities after positive combined first-trimester screening in Chinese women: a retrospective cohort study. BMC Pregnancy Childbirth. 2019;19. doi:10.1186/s12884-019-2205-y
   Web of Science ®Google Scholar
• Tang Y, Luo H, Mu D, et al.Early diagnosis of trisomy 21, trisomy 18 and trisomy 13 using nuchal translucency thickness and ductus venosus blood flow waveform in West China. Mol Med Rep. 2018;19:1349–1355.
   PubMed Web of Science ®Google Scholar
• Tercanli S, Miny P, Filges I. Increased fetal nuchal translucency - also a risk for a rare submicroscopic chromosomal abnormalities. Ultraschall in Der Medizin. 2015;36:419–420.
   PubMed Web of Science ®Google Scholar
• Socolov D, Socolov R, Gorduza VE, et al. Increased nuchal translucency in fetuses with a normal karyotype—diagnosis and management: an observational study. Medicine. 2017;96:e7521. doi:10.1097/MD.0000000000007521
   PubMed Web of Science ®Google Scholar
• Le Lous M, Bouhanna P, Colmant C, et al. The performance of an intermediate 16th-week ultrasound scan for the follow-up of euploid fetuses with increased nuchal translucency. Prenat Diagn. 2016;36:148–153. doi:10.1002/pd.4756
   PubMed Web of Science ®Google Scholar
• Kane SC, Reidy KL, Norris F, et al. Chorionic villus sampling in the cell-free DNA aneuploidy screening era: careful selection criteria can maximise the clinical utility of screening and invasive testing. Prenat Diagn. 2017;37:399–408. doi:10.1002/pd.5026
   PubMed Web of Science ®Google Scholar
• Lithner CU, Kublickas M, Ek S. Pregnancy outcome for fetuses with increased nuchal translucency but normal Karyotype. J Med Screen. 2015;23:1–6.
   PubMed Web of Science ®Google Scholar
• Ztürk FH, Cal FD, Erol SA, et al. Fetal genetic diagnosis by chorionic villus sampling: evaluation of the five-year experience from a single center. Fetal Pediatr Pathol. 2020;3:1–9.
   Google Scholar